Mary was diagnosed with Crohn’s Disease by the time she was 28 years old. Just like her mom. She longed for a social life but most importantly she was scared that she was going to lose the ability to support herself financially — the missed work days were adding up.
The researchers and drug developers who are working to find solutions to the problems Mary and millions of others are faced with need ways of better understanding the differences that make us human. Analytic Morphomics offers new insights into the heterogeneity of the population, knowledge that helps match patients to the right drug and the right dose, for the right outcome.
This is where precision medicine comes in. < Read our published work > where we have proven the value of Morphomics for accurate drug dosing.